Results 221 to 230 of about 1,390,389 (383)

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Efficacy of local radiotherapy in first-line treatment of recurrent or metastatic esophageal squamous cell carcinoma based on immunotherapy. [PDF]

BMC Cancer
Yu D, Li F, Xu L, Xia X, Sun X, Ge X.
europepmc   +1 more source

To the radiotherapy of cervical cancers. Laborde (by Veg. ü. d. ges Gyn., Bd. XII)

, 1928
A. Timofeev
openalex   +2 more sources

In situ epidermoid carcinoma of the cervix and vagina following radiotherapy for cervical cancer [PDF]

, 1961
Leopold G. Koss, Myron R. Melamed, William W. Daniel   +2 more
openalex   +1 more source

Radiotherapy and Cancer [PDF]

Postgraduate Medical Journal, 1946
openaire   +4 more sources

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

The effect of hospital teaching status on adverse outcomes among breast cancer patients receiving radiotherapy and brachytherapy. [PDF]

Medicine (Baltimore)
Zhong Y, Liu B, Zhou J, Ge Y, Rui N, Shen L, Yang F.   +6 more
europepmc   +1 more source

Radiotherapy in locally advanced cancer of the breast. Adjunct to standard therapy [PDF]

, 1967
Ruth Guttmann
openalex   +1 more source

Characterizing epithelial‐mesenchymal transition‐linked heterogeneity in breast cancer circulating tumor cells at a single‐cell level

Molecular Oncology, EarlyView.
In over 50% of non‐metastatic breast cancer patients, circulating tumor cells (CTCs) along the whole epithelial‐mesenchymal transition spectrum are detected. Total CTC number and individual phenotypes relate to aggressive disease characteristics, including lymph node involvement and higher tumor proliferation. At the single‐cell level, mesenchymal CTCs
Justyna Topa, Julia Richert, Tomasz Stokowy, Alicja Staśczak, Mariusz Szajewski, Maciej Ciesielski, Petra M. Grešner, Bartłomiej Tomasik, Łukasz Arcimowicz, Agnieszka Stankiewicz, Grażyna Suchodolska, Elżbieta Senkus, Wiesław Kruszewski, Anna J. Żaczek, Aleksandra Markiewicz   +14 more
wiley   +1 more source

Once- or twice-daily thoracic radiation in limited-stage small-cell lung cancer treated with concurrent chemoradiotherapy. [PDF]

Cochrane Database Syst Rev
Harada K, Inoki K, Ichimura T, Taruno K, Shinjo H, Yamaji N, Noma H, Ota E, Hasegawa T.   +8 more
europepmc   +1 more source